Rifaximin

Rifaximin 100 mg/5 ml Oral Suspension is a non-systemic, gastrointestinal-targeted antibiotic formulated to treat bacterial infections of the digestive tract. Unlike conventional antibiotics that enter the bloodstream, this oral liquid acts locally inside the intestines. It provides targeted therapy against enteric pathogens while maintaining an excellent safety profile with minimal body-wide side effects. This pleasant-tasting liquid format is specifically designed for pediatric patients and adults who cannot swallow solid pills. Rifaximin oral tablets are prescribed in 200 mg, 400 mg, and 550 mg strengths, with each dosage tailored to target a specific gastrointestinal condition. Because rifaximin functions locally within the gut with minimal systemic blood absorption, the exact tablet milligram strength and daily dosing frequency directly determine its therapeutic focus.